Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
uterine cervical dysplasia
MeSH D002578 - uterine cervical dysplasia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002577:
Uterine cervical diseases
0 Companies
0 Drugs
Success rate
D011230:
Precancerous conditions
0 Companies
0 Drugs
Success rate
D002578:
Uterine cervical dysplasia
2 Companies
0 Drugs
Success rate
D065309:
Atypical squamous cells of the cervix
0 Companies
0 Drugs
Success rate
D065310:
Squamous intraepithelial lesions of the cervix
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100
%
4/4
Phase 2
22
%
2/9
Phase 3
0
%
0/6
Approved:
0
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Transplatin
,
Antithrombin iii
,
Gardasil
Merck & Co
Ademetionine
,
Sodium chloride
,
Gardasil
,
Mk3475
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use